comparemela.com

Latest Breaking News On - Analyst event - Page 4 : comparemela.com

Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates

Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
United-states
Canada
Massachusetts
Australia
Cambridge
Cambridgeshire
Boston
Sanofi-pasteur
Lavina-talukdar
Chris-ridley
Nasdaq

Longboard Pharmaceuticals Announces Speakers for Investor & Analyst Event in New York on October 11, 2023

Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the speakers for its.

United-states
Ukraine
New-york
Australia
Philadelphia
Pennsylvania
Gabrielle-conecker
Dennis-dlugos
A-alliance
Nasdaq
Exchange-commission
Longboard-pharmaceuticals-inc

Marinus Pharmaceuticals Highlights Advancing Pipeline and Commercial Strategy at Investor and Analyst Event

RADNOR - Marinus Pharmaceuticals, Inc. , a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, is today hosting an Investor and Analyst Event in.

New-york
United-states
Rajat-dhar
Jim-denike
Scott-braunstein
Washington-university-school-of-medicine
Nasdaq
Us-department-of-health
Human-services
Exchange-commission
Biomedical-advanced-research
Marinus-pharmaceuticals

Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on October 11, 2023

Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it will host an.

New-york
United-states
Ukraine
Australia
Longboard-pharmaceuticals
Longboard-pharmaceuticals-inc
Exchange-commission
Nasdaq
Analyst-event
Epileptic-encephalopathy
Investor-relations

Marinus Pharmaceuticals stock surges on financial guidance

Marinus (NASDAQ:MRNS) Pharmaceuticals Inc shares climbed 20% to $7.02 on Tuesday after the pharmaceutical company dedicated to the development of.

New-york
United-states
Scott-braunstein
Marinus-pharmaceuticals
Pharmaceuticals-inc
Analyst-event

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.